Continuation of same programmed death-1 inhibitor regime beyond progression is a novel option for advanced gastric cancer. - Li, Jiasong; Ding, Fang; Zhang, Shasha; Jia, Yuanyuan; Zhang, Tianhang; Wang, Siqi; Liu, Qingyi; Guo, Zhanjun (BMC Cancer, 2024)